The Johns Hopkins Right Ventricular Dysplasia Program was formed in order to provide specialized evaluation and care for patients with ARVD/C. The program, headed by Dr. Hugh Calkins, also focuses on clinical and genetic research.
Our Staff
Hugh Calkins, MD is the Director of the Arrhythmias Service and the Clinical Electrophysiology Laboratory. He sees patients, reviews medical records, and is available for consultation.
Hari Tandri , MD joined the program in August 2001 as a Post-doctoral Fellow. His main focus was on imaging techniques and developing methods to quantify abnormalities seen on echocardiography and magnetic resonance imaging. Dr. Tandri completed his Electrophysiology Fellowship here at Hopkins and joined the faculty as Assistant Professor in July 2008. He continues to work on various research projects on ARVD and now sees patients in consultation through the ARVD Program.
Crystal Tichnell, MGC joined the program in June 2002 as one of the ARVD Program Coordinators, as well as a Genetic Counselor. She received her Masters in Genetic Counseling from the University of Maryland School of Medicine in 2002. She coordinates clinical and research activities by scheduling patients and enrolling patients in various research projects.
Cynthia James, ScM, PhD joined the program in September 2002 and is one of the ARVD Program Coordinators. She received her ScM in Genetic Counseling in 2000 from The Johns Hopkins University/National Human Genome Research Institute Genetic Counseling Training Program. She received her PhD in Human Genetics in 2003 from the Johns Hopkins School of Medicine. She is a genetic counselor/geneticist and coordinates various research projects. She also coordinates patient appointments and writes grants for future projects.
Darshan Dalal, MD, MPH joined the program in June 2003 and is our database manager. He has redesigned our research database and continuously organizes our data. He has published a number of abstracts and manuscripts and provides statistical support for various research projects.
Rahul Jain, MD joined the ARVD program in July 2008 as a Postdoctoral Fellow. His primary focus will be on electrocardiography in ARVD. He will also be working on the Predictors of ICD Firing Study.
Philip
Spevak, MD is the Pediatric Cardiologist coordinating efforts to
learn more about testing children for ARVD with echocardiography. Dr.
Spevak is available for consultation.
Jane
Crosson, MD is a pediatric cardiologist with special interests in pediatric
rhythm disturbances, pacemakers, syncope and fetal cardiology. She
is available for consultations regarding ARVD
Hal
Dietz, MD is a Pediatric Cardiologist and Geneticist who runs a
molecular research laboratory. He will be conducting the research on
DNA samples obtained from patients with ARVD.
Daniel
Judge , MD, Associate Professor of Medicine, is a heart failure
specialist with a research interest in familial cardiomyopathies. Dr.
Judge is conducting research on DNA samples obtained from patients with
ARVD.
Stuart
Russell, MD is the clinical director of The
Johns Hopkins Cardiomyopathy and Heart Transplantation Practice. He has
a special interest in the effects of exercise, heart failure, and new
therapies for heart failure.
Theodore
Abraham, MD, Associate Professor of Medicine, is a cardiologist
who recently joined the faculty at Johns Hopkins. His expertise is
in echocardiography imaging techniques, in particular, how to visualize
the right ventricle.
David Bluemke, MD, PhD is a radiologist working on quantifying cardiac MRIs in order to improve the diagnostic value of this test. He is serves as the core MRI laboratory for the NIH-funded Multidisciplinary Study of Right Ventricular Dysplasia.
Brittney Dye, MS joined the program in May 2010 as a Genetic Counselor. She received her MS in Human Genetics, Genetic Counseling at the University of Michigan in 2010. She coordinates both clinical and research activities by meeting with patients and enrolling them in various research projects.
Aditya Bhonsale, MD joined the program in July 2010 as a Post Doctoral Research Fellow after completing his Internal Medicine residency. His primary focus is on the incidence and predictors of appropriate ICD intervention in primary prevention ARVD patients.
Dmitri Gagarin, MD joined the program in August 2010 as a Research Fellow after completing his residency at Harbor Hospital. He also worked with the ARVD program in 2009 as a trainee. His primary focus is to analyze the efficacy of different classes of antiarrhythmic drugs in VT prevention in patients who have received ICDs for secondary prevention.